Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | THRB | P10828 | 1/20 | 0.66 |
| ▸ | MTOR | P42345 | 1/20 | 0.66 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.66 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.66 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.66 |
| ▸ | NT5E | P21589 | 1/20 | 0.54 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.48 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.47 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.47 |
| ▸ | ALB | P02768 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.47 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.47 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26986754 | 1.00 | LMNA (0.66) | LMNATHRBMTORMDM2NCOA1 | |
| Hydrochloric Acid SCHEMBL15663884 | 0.99 | LMNA (0.64) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL12472103 | 0.90 | LMNA (0.64) | LMNATHRBMTORMDM2NCOA1 | |
| Benzoic Acid SCHEMBL1843659 | 0.89 | LMNA (0.55) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL18911166 | 0.83 | LMNA (0.56) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL2835710 | 0.83 | LMNA (0.69) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL15663551 | 0.83 | LMNA (0.50) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL4879682 | 0.82 | LMNA (0.67) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL10015791 | 0.82 | LMNA (0.67) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL399323 | 0.82 | LMNA (0.67) | LMNATHRBMTORMDM2NCOA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 14454 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746876-A1 | UDP-GLUCOSE CERAMIDE GLUCOSYLTRANSFERASE SYNTHASE (UGCG) INHIBITORS IN THE TREATMENT OF CANCER | Katholieke Universiteit Leuven (BE) | 2026-05-27 | — | — | EP | claimed |
| CN-116209439-B | Cereblon protein modulators | Saint Jude Children's Research Hospital Ltd. (US) | 2026-05-26 | — | — | CN | claimed |
| CN-122070932-A | Application of combination of decitabine and anti-HER 2 antibody in preparation of medicines for treating tumors | 上海交通大学 | 2026-05-22 | — | — | CN | claimed |
| US-20260137674-A1 | COMBINATION THERAPY USING A KRAS G12D INHIBITOR, AND A NUCLEOSIDE ANALOG, AND/OR A MICROTUBULE INHIBITOR | INCYTE CORP (US) | 2026-05-21 | — | — | US | claimed |
| CN-122056884-A | Methods of treating pancreatic cancer | 坎莫森特里克斯公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122028920-A | Method for treating hematological cancer | 丹娜-法伯癌症研究院 | 2026-05-12 | — | — | CN | claimed |
| CN-122028934-A | Combination of CLDN18_2 antibody and chemotherapeutic drug and application thereof | 江苏奥赛康生物医药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122004132-A | Method for establishing efficient regeneration system of fenugreek | 新疆维吾尔自治区药物研究院 | 2026-05-12 | — | — | CN | claimed |
| US-20260124190-A1 | METHOD FOR TREATING A DISEASE OR CONDITION USING A PYRAZOLE COMPOUND OR FORMULATION THEREOF | RIGEL PHARMACEUTICALS, INC. (US) | 2026-05-07 | — | — | US | claimed |
| WO-2026090323-A1 | COMBINATION THERAPY USING A KRAS G12D INHIBITOR, AND A NUCLEOSIDE ANALOG, AND/OR A MICROTUBULE INHIBITOR AND ITS USE IN THE TREATMENT OF CANCER | INCYTE CORPORATION (US) | 2026-04-30 | — | — | WO | claimed |
| CN-1309180-A | Multi-mesoblast pedigree differential potency for stromal cell from fatty tissue, and its use | ZEN BIO INC (US) | 2001-08-22 | — | — | CN | claimed |
| US-6106866-A | ANTITUMOR AGENTS AND DERMATAN SULFATE | ACCESS PHARMACEUTICALS, INC. (US) | 2000-08-22 | — | — | US | claimed |
| EP-0794796-A1 | COMPLEXES OF DERMATAN SULFATE AND DRUGS, GIVING IMPROVED PHARMACOKINETICS | Access Pharmaceuticals, Inc. (US) | 1997-09-17 | — | — | EP | claimed |
| WO-1996040091-A1 | DUAL FUNCTIONAL CYTOTOXIC/RADIOSENSITIZER COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF | VIVORX PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996019242-A1 | COMPLEXES OF DERMATAN SULFATE AND DRUGS, GIVING IMPROVED PHARMACOKINETICS | ACCESS PHARMACEUTICALS, INC. (US) | 1996-06-27 | — | — | WO | claimed |
| WO-1995028404-A1 | 7,11 DISUBSTITUTED CAMPTOTHECIN DERIVATIVES, FORMULATIONS CONTAINING SUCH DERIVATIVES AND THEIR USE | BIONUMERIK PHARMACEUTICALS, INC. (US) | 1995-10-26 | — | — | WO | claimed |
| EP-0282160-B1 | A method of obtaining a retrovirus-containing fraction from retrovirus-containing cells | UNIV LIVERPOOL (GB) | 1995-05-10 | — | — | EP | claimed |
| US-5324831-A | Phosphoramidite reagent for chemical synthesis of modified DNA | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF HEALTH AND HUMAN SERVICES (US) | 1994-06-28 | — | — | US | claimed |
| EP-0282160-A2 | A method of obtaining a retrovirus-containing fraction from retrovirus-containing cells | THE UNIVERSITY OF LIVERPOOL (GB) | 1988-09-14 | — | — | EP | claimed |
| EP-0262696-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1988-04-06 | — | — | EP | claimed |